The global tyrosine protein kinase receptor market is anticipated to grow at a significant CAGR during the forecast period. Receptor tyrosine kinases (RTKs) are high-affinity cell surface receptors for many polypeptide growth factors such as cytokines and hormones. Additionally, these receptors are activated by the ligands that is binding them to their extracellular domain. The major factor accelerating the growth of the market is the increasing prevalence of cancer across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/tyrosine-protein-kinase-receptor-market
According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases in 2018 which is anticipated to rise to 29.5 million by 2040. Hence, the rising prevalence of cancer is supporting the demand for tyrosine kinase receptors which in turn is driving the growth of the market.
Some major players in the market include Bayer AG, Boehringer Ingelheim International, and AstraZeneca plc among others. Moreover, based on type, the market is segmented into epidermal growth factor receptor (EGFR)-, vascular endothelial growth factor receptor (VEGFR)-, platelet-derived growth factor receptor (PDGFR) – tyrosine kinase inhibitors, and others. VEGFR-TKIs is expected to hold a prominent share in the market owing to its application in the treatment of lung cancer, which is the most common type of cancer globally.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Bayer AG, Boehringer Ingelheim International, and AstraZeneca plc among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Tyrosine Protein Kinase Receptor Market Report by Segment
By Type
- Epidermal Growth Factor Receptor (EGFR)
- Vascular Endothelial Growth Factor Receptor (VEGFR)
- Platelet-Derived Growth Factor Receptor (PDGFR)
- Others
By Application
- Lung Cancer
- Breast Cancer
- Renal Cell Cancer
- Others
A full report of Tyrosine Protein Kinase Receptor Market is available at: https://www.omrglobal.com/industry-reports/tyrosine-protein-kinase-receptor-market
Tyrosine Protein Kinase Receptor Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Bayer AG
- Boehringer Ingelheim International
- AstraZeneca plc
